| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/11/2010 | US20100286164 Substituted aryl alkylamino-oxy-analogs and uses thereof |
| 11/11/2010 | US20100286163 Indolo[3,2-c]quinoline compounds |
| 11/11/2010 | US20100286162 Human papilloma virus inhibitors and pharmaceutical compositions containing same |
| 11/11/2010 | US20100286161 Pyrazine derivatives and their use as potassium channel modulators |
| 11/11/2010 | US20100286160 Substituted piperazines as cb1 antagonists |
| 11/11/2010 | US20100286159 Pyridazines |
| 11/11/2010 | US20100286158 Dihydropyrimidinones |
| 11/11/2010 | US20100286157 4- [3- (4-cyclopropanecarbonyl-piperazine-i-carbonyl) -4 -fluoro-benzyl] -2h-phthalaz in-1-one |
| 11/11/2010 | US20100286156 Collyrium For The Treatment Of Conical Cornea With Cross-Linking Trans-Epithelial Technique |
| 11/11/2010 | US20100286155 Adrenocortical carcinoma treatment |
| 11/11/2010 | US20100286154 Antihelmintic paste |
| 11/11/2010 | US20100286153 Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level |
| 11/11/2010 | US20100286152 N-phenyl hydrazides as modulators of the ghrelin receptor |
| 11/11/2010 | US20100286151 1-OXA-3-Azaspiro[4,5]Decan--2-One Derivatives For The Treatment Of Eating Disorders |
| 11/11/2010 | US20100286150 Levosimendan for use in treating chronic valvular disease |
| 11/11/2010 | US20100286149 Novel benzamide derivatives useful as potassium channel modulators |
| 11/11/2010 | US20100286147 Fungicidal amides |
| 11/11/2010 | US20100286146 Carboxamide compounds and their use as calpain inhibitors |
| 11/11/2010 | US20100286145 Isophthalamide derivatives inhibiting beta-secretase activity |
| 11/11/2010 | US20100286144 Heteroaryl derivatives |
| 11/11/2010 | US20100286143 Methods and materials for genetic analysis of tumors |
| 11/11/2010 | US20100286142 Compounds and Methods for Kinase Modulation, and Indications Therefor |
| 11/11/2010 | US20100286141 Compositions and Methods for Identifying Agents Which Modulate PTEN Function and PI-3 Kinase Pathways |
| 11/11/2010 | US20100286140 Triazolophthalazines |
| 11/11/2010 | US20100286139 Amino pyrazole compound |
| 11/11/2010 | US20100286138 Stable forms of N-(2,6-Dimethyl-4-morpholin-4-yl-phenyl)-3,3-dimethyl-butyramide |
| 11/11/2010 | US20100286137 Method of Treating Conditions Involving PPAR-Receptors with Indole Compounds |
| 11/11/2010 | US20100286136 Dihydronaphthyridinyl and related compounds for use in treating ophthalmological disorders |
| 11/11/2010 | US20100286135 Heterocyclic amide compounds as protein kinase inhibitors |
| 11/11/2010 | US20100286134 Novel phenoxazin-3-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 11/11/2010 | US20100286133 Diacyl indazole derivatives as lipase and phospholipase inhibitors |
| 11/11/2010 | US20100286132 Pyridines |
| 11/11/2010 | US20100286131 Viral polymerase inhibitors |
| 11/11/2010 | US20100286130 Antimicrobial compounds, their synthesis and their use for treatment of mammalian infections |
| 11/11/2010 | US20100286129 Novel benzimidazoledihydrothiadiazinone derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same |
| 11/11/2010 | US20100286128 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivatives useful as nicotinic acetylcholine-receptor ligands |
| 11/11/2010 | US20100286127 Antitumor agent |
| 11/11/2010 | US20100286126 Organic Compounds |
| 11/11/2010 | US20100286125 Hydroxamic acid derivatives of 4-phenyl 4-hydroxy, 4-phenyl 4-alkoxy and 4-phenyl 4-arylalkoxy butyric acid useful as therapeutic agents for treating anthrax poisoning |
| 11/11/2010 | US20100286124 Prop-2-yn-1-amine inhibitors of monoamine oxidase type b |
| 11/11/2010 | US20100286123 Inhibitors of the renal outer medullary potassium channel |
| 11/11/2010 | US20100286122 CGRP Antagonist Salt |
| 11/11/2010 | US20100286121 Water-Immiscible Materials as Vehicles for Drug Delivery |
| 11/11/2010 | US20100286120 Pyridooxazepine derivative and use thereof |
| 11/11/2010 | US20100286119 N-(Aminoheteroaryl)-1H-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof |
| 11/11/2010 | US20100286118 Substituted 1-cyanoethylheterocyclylcarboxamide compounds 750 |
| 11/11/2010 | US20100286117 Pyridines |
| 11/11/2010 | US20100286116 Thiazoles |
| 11/11/2010 | US20100286115 Pyrazoles |
| 11/11/2010 | US20100286114 Hedgehog pathway antagonists and therapeutic applications thereof |
| 11/11/2010 | US20100286113 Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors |
| 11/11/2010 | US20100286112 Compounds for the treatment of metabolic disorders |
| 11/11/2010 | US20100286111 Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level |
| 11/11/2010 | US20100286110 Azetidinyl g-protein coupled receptor agonists |
| 11/11/2010 | US20100286109 Amide derivatives as positive allosteric modulators and methods of use thereof |
| 11/11/2010 | US20100286108 Stabilized Steroid Composition and Method for its Preparation |
| 11/11/2010 | US20100286107 Oligomer-Corticosteroid Conjugates |
| 11/11/2010 | US20100286106 Methods and apparatus for treating the prostate |
| 11/11/2010 | US20100286105 Methods of treating hyperandrogenism and conditions associated therewith by administering a fatty acid ester of an estrogen or an estrogen derivative |
| 11/11/2010 | US20100286104 Agent for inhibiting visceral fat accumulation |
| 11/11/2010 | US20100286103 Heterocycle-aryl compounds for inflammation and immune-related uses |
| 11/11/2010 | US20100286102 Formulations comprising ceramides and/or pseudoceramides and (alpha-)bisabolol for combating skin damage |
| 11/11/2010 | US20100286101 Pharmaceutical composition including a corticosteroid and a vitamin d analog having improved stability |
| 11/11/2010 | US20100286100 Method and composition to improve absorption of therapeutic agents |
| 11/11/2010 | US20100286099 Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine |
| 11/11/2010 | US20100286098 Use of tetrahydrocannabinol and/or cannabidiol for the treatment of inflammatory bowel disease |
| 11/11/2010 | US20100286097 Insecticidal compositions |
| 11/11/2010 | US20100286095 Novel use of a polyamine-depleted food composition for human or veterinary use, for preparing a therapeutic food product |
| 11/11/2010 | US20100286094 Novel compounds of reverse turn mimetics and the use thereof |
| 11/11/2010 | US20100286093 Anti-inflammatory composition containing docosahexaenoyl lysophosphatidylamine as an active ingredient |
| 11/11/2010 | US20100286092 Beta-lactamase inhibitors |
| 11/11/2010 | US20100286091 Imidazolidinone compounds, methods to inhibit deubiquitination and methods of treatment |
| 11/11/2010 | US20100286090 Treatment of Multiple Myeloma |
| 11/11/2010 | US20100286089 Process for the Preparation of Entecavir and Novel Intermediates Thereof Via Carbon-Silicon Oxidation |
| 11/11/2010 | US20100286088 3-Substituted-4-Oxo-3,4-Dihydro-Imidazo[5,1-d][1,2,3,5-Tetrazine-8-Carboxylic Acid Amides and Their Use |
| 11/11/2010 | US20100286087 Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases |
| 11/11/2010 | US20100286086 Composition for the treatment of osteoarthritis |
| 11/11/2010 | US20100286085 Novel chondroitin sulfate having decreased molecular weight and use thereof |
| 11/11/2010 | US20100286084 Oligomer-Nucleoside Phosphate Conjugates |
| 11/11/2010 | US20100286083 Nucleoside analogs |
| 11/11/2010 | US20100286082 Riboswitches and methods and compositions for use of and with riboswitches |
| 11/11/2010 | US20100286081 5-amino-3-(2',3'-di-o-acetyl-beta-d-ribofuranosyl)-3h-thiazolo[4,5-d] pyrimidin-2-oce salts and crystalline forms |
| 11/11/2010 | US20100286080 Aqueous composition comprising chitosan and an acidic drug |
| 11/11/2010 | US20100286079 Composition comprising covalent conjugates of chitosan and an acidic drug and parenteral administration |
| 11/11/2010 | US20100286078 Topical ophthalmic compositions containing tobramycin and dexamethasone |
| 11/11/2010 | US20100286077 Compounds |
| 11/11/2010 | US20100286075 Amphiphilic block copolymer micelle composition containing taxane and manufacturing process of the same |
| 11/11/2010 | US20100286074 Pharmaceutical use of ginsenoside or mixture thereof and pharmaceutical composition of ginsenoside and use thereof |
| 11/11/2010 | US20100286073 Compounds and methods for pharmaceutical use |
| 11/11/2010 | US20100286065 Topical methods and compositions for the treatment of eye diseases and conditions |
| 11/11/2010 | US20100286063 GNRH agonist combination drugs |
| 11/11/2010 | US20100286060 Specific binding agents of human angiopoeitin-2 |
| 11/11/2010 | US20100286059 Use of opioid antagonists |
| 11/11/2010 | US20100286058 Assessing Chemotherapy Resistance of Colorectal Tumors by Determining Sparc Hypermethylation |
| 11/11/2010 | US20100286049 Polycystic kidney disease-related gene and use thereof |
| 11/11/2010 | US20100286046 Modified h2 relaxin for tumor suppression |
| 11/11/2010 | US20100286041 (5z)-5-(6-quinoxalinylmethylidene)-2-[(2,6-dichlorophenyl)amino]-1,3-thiazol-4(5h)-one |
| 11/11/2010 | US20100286038 Formulation containing cyclin-dependent kinase inhibiting compound and method of treating tumors using the same |
| 11/11/2010 | US20100286032 Prodrugs of hiv protease inhibitors |
| 11/11/2010 | US20100286031 Antibiotic Formulations, Unit Doses, Kits and Methods |